BELINDA CHAMBERS: Open Payments
NPI 1578240974 · SOCIAL CIRCLE, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$497 in 27 payments from 13 companies in 2025. Trend: 2023 $67 · 2024 $543 · 2025 $497
Food & beverage: $497
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 6 | $103 |
| Lilly USA, LLC | 3 | $56 |
| AstraZeneca Pharmaceuticals LP | 3 | $52 |
| PFIZER INC. | 2 | $48 |
| SANOFI-AVENTIS U.S. LLC | 2 | $42 |
| ABBVIE INC. | 2 | $38 |
| Amgen Inc. | 2 | $32 |
| Merck Sharp & Dohme LLC | 2 | $30 |
| Actelion Pharmaceuticals US, Inc. | 1 | $22 |
| Corcept Therapeutics | 1 | $22 |
Products named: MOUNJARO, AIRSUPRA, PREVNAR 20, TZIELD, Wegovy, Rybelsus, Ozempic, REPATHA.
Industry payments across GA — which companies pay providers there.
